ÌÇÐÄÆƽâ°æ

In 2024, almost ** people were confirmed to have hemophilia worldwide. At that time, a further ** people were living with von Willebrand disease. Both of these bleeding disorders are genetic diseases that prevent blood from clotting normally. 

Bleeding disorders

There are multiple types of hemophilia and bleeding disorders, including hemophilia A and B, as well as various platelet disorders. Globally, hemophilia A has the largest number of people living with a bleeding disorder, followed by von Willebrand disease. Life expectancy for people with hemophilia has dramatically increased since the advent of treatments to help combat the disorder. Modern medical treatments have extended the life expectancy of a hemophilia patient from 30 to 68 years.

U.S. market

In the U.S. alone there are over ** thousand patients with hemophilia and ** thousand with von Willebrand disease. Hemophilia A is more common than hemophilia B. In the U.S., around ** thousand patients had hemophilia A as of 2023. Comparatively, just under *** thousand patients had hemophilia B at that time. While hemophilia and other bleeding disorders can affect persons of any ethnicity, von Willebrand patients in the U.S. are largely white or Caucasian. In 2023, around ** percent of von Willebrand patients were white.